Vaginal Erbium Laser Versus Pelvic Floor Muscle Training for Stress Urinary Incontinence: A Randomised Controlled Trial

Overview

Journal Int Urogynecol J

Publisher Springer

Specialties Gynecology & Obstetrics
Urology

Date 2025 Mar 13

PMID 40080112

Authors

Ann-Sophie Page

Eline Borowski

Emma Bauters

Susanne Housmans

Frank Van der Aa

Jan Deprest

Affiliations

Soon will be listed here.

Abstract

Introduction And Hypothesis: Current studies on vaginal laser therapy for the management of stress urinary incontinence (SUI) are inconclusive, and many lack comparison with another conservative treatment. Therefore, we compared the efficacy of Er:YAG laser for SUI with that of pelvic floor muscle training (PFMT).

Methods: Single-centre, randomised controlled trial comparing laser treatment (3-6 applications) with PFMT (9-18 sessions) in women with mild to moderate SUI. Main outcome measures included subjective change in urinary incontinence symptoms by change from baseline to 4 months after randomisation by Urogenital Distress Inventory-6 (UDI-6; primary), adverse events, and other subjective and objective outcomes up to 24 months. A priori sample size calculation for a non-inferiority study resulted in 28 patients per arm. Because of a higher than expected dropout early in the study, we increased our sample size from 56 to 60, without unblinding of the data.

Results: Sixty women were enrolled. Two participants discontinued their allocated treatment (one in each group). At 4 months, mean difference in change in UDI-6 scores was -6.99 (95% CI = -22.34; 8.37), demonstrating non-inferiority of laser to PFMT (p = 0.023). Within groups, most patients improved, yet subjective cure was reached in only a minority (laser: 11% [3 out of 28]; PFMT: 8% [2 out of 26]). The mean number of treatment visits was 4.25 (SD 1.17) in the laser group and 10.04 (SD 6.36) in the PFMT group. There were no subjective or objective inter-group differences. At 24 months, the majority of patients requested additional, yet alternative treatment. There were no serious adverse events at any time point.

Conclusions: Treatment effect of vaginal laser and PFMT in patients with mild and moderate SUI were comparable, limited and short lasting. No adverse events were reported.

References

Milsom I, Gyhagen M . The prevalence of urinary incontinence. Climacteric. 2018; 22(3):217-222. DOI: 10.1080/13697137.2018.1543263. View

Richter H, Burgio K, Brubaker L, Nygaard I, Ye W, Weidner A . Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol. 2010; 115(3):609-617. PMC: 2914312. DOI: 10.1097/AOG.0b013e3181d055d4. View

Dumoulin C, Cacciari L, Hay-Smith E . Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018; 10:CD005654. PMC: 6516955. DOI: 10.1002/14651858.CD005654.pub4. View

Bo K, Hilde G . Does it work in the long term?--A systematic review on pelvic floor muscle training for female stress urinary incontinence. Neurourol Urodyn. 2012; 32(3):215-23. DOI: 10.1002/nau.22292. View

Schellart R, Casteleijn F, Dijkgraaf M, Tutolo M, Roovers J . Are patients willing to trade cure rate against less pain? Patients' preferences for single incision midurethral sling or transobturator standard midurethral sling. Neurourol Urodyn. 2016; 36(4):1187-1193. DOI: 10.1002/nau.23093. View

Bhide A, Khullar V, Swift S, Digesu G . The use of laser in urogynaecology. Int Urogynecol J. 2018; 30(5):683-692. PMC: 6491394. DOI: 10.1007/s00192-018-3844-7. View

Giarenis I, Tsiapakidou S, Zacche M, Mukhopadhyay S, Mahmood T . European Board and College of Obstetrics and Gynaecology (EBCOG) position statement on the use of laser vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, pelvic organ prolapse and stress urinary incontinence. Eur J Obstet Gynecol Reprod Biol. 2024; 299:342-344. DOI: 10.1016/j.ejogrb.2024.05.021. View

da Fonseca L, Giarreta F, Peterson T, Locali P, Baracat E, Ferreira E . A randomized trial comparing vaginal laser therapy and pelvic floor physical therapy for treating women with stress urinary incontinence. Neurourol Urodyn. 2023; 42(7):1445-1454. DOI: 10.1002/nau.25244. View

Blaganje M, Scepanovic D, Zgur L, Verdenik I, Pajk F, Lukanovic A . Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2018; 224:153-158. DOI: 10.1016/j.ejogrb.2018.03.038. View

10.

Seki A, Bianchi-Ferraro A, Fonseca E, Sartori M, Girao M, Jarmy-Di Bella Z . CO Laser and radiofrequency compared to a sham control group in treatment of stress urinary incontinence (LARF study arm 3). A randomized controlled trial. Int Urogynecol J. 2022; 33(12):3535-3542. DOI: 10.1007/s00192-022-05091-y. View

11.

Lauterbach R, Aharoni S, Justman N, Farago N, Gruenwald I, Lowenstein L . The efficacy and safety of a single maintenance laser treatment for stress urinary incontinence: a double-blinded randomized controlled trial. Int Urogynecol J. 2022; 33(12):3499-3504. PMC: 8864590. DOI: 10.1007/s00192-022-05103-x. View

12.

Alexander J, Karjalainen P, Ow L, Kulkarni M, Lee J, Karjalainen T . CO surgical laser for treatment of stress urinary incontinence in women: a randomized controlled trial. Am J Obstet Gynecol. 2022; 227(3):473.e1-473.e12. DOI: 10.1016/j.ajog.2022.05.054. View

13.

OReilly B, Viereck V, Phillips C, Toozs-Hobson P, Kuhn A, Athanasiou S . Vaginal erbium laser treatment for stress urinary incontinence: A multicenter randomized sham-controlled clinical trial. Int J Gynaecol Obstet. 2023; 164(3):1184-1194. DOI: 10.1002/ijgo.15222. View

14.

Temtanakitpaisan T, Chongsomchai C, Buppasiri P . Fractional CO laser treatment for women with stress predominant urinary incontinence: a randomized controlled trial. Int Urogynecol J. 2023; 34(11):2827-2832. DOI: 10.1007/s00192-023-05655-6. View

15.

Sandvik H, Espuna M, Hunskaar S . Validity of the incontinence severity index: comparison with pad-weighing tests. Int Urogynecol J Pelvic Floor Dysfunct. 2006; 17(5):520-4. DOI: 10.1007/s00192-005-0060-z. View

16.

Pardo J, Sola V, Morales A . Treatment of female stress urinary incontinence with Erbium-YAG laser in non-ablative mode. Eur J Obstet Gynecol Reprod Biol. 2016; 204:1-4. DOI: 10.1016/j.ejogrb.2016.06.031. View

17.

Fistonic N, Fistonic I, Gustek S, Turina I, Marton I, Vizintin Z . Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women--a pilot study. Lasers Med Sci. 2016; 31(4):635-43. PMC: 4851697. DOI: 10.1007/s10103-016-1884-0. View

18.

Shumaker S, Wyman J, Uebersax J, McClish D, Fantl J . Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res. 1994; 3(5):291-306. DOI: 10.1007/BF00451721. View

19.

Barber M, Chen Z, Lukacz E, Markland A, Wai C, Brubaker L . Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). Neurourol Urodyn. 2011; 30(4):541-6. PMC: 3759146. DOI: 10.1002/nau.20934. View

20.

Barber M, Spino C, Janz N, Brubaker L, Nygaard I, Nager C . The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Am J Obstet Gynecol. 2009; 200(5):580.e1-7. PMC: 2680021. DOI: 10.1016/j.ajog.2009.02.007. View